mRNA疫苗平台:mRNA生产和输送
V R Litvinova1, A P Rudometov1, L I Karpenko1
1State Research Center of Virology and Biotechnology "Vector", Federal Service for Surveillance on Consumer Rights Protection and Human Welfare, 630559 Koltsovo, Novosibirsk Region Russia.
传递 RNA (mRNA) 疫苗为预防传染病提供了一种安全且可适应的方法. 本综述涵盖了mRNA疫苗史,生产,稳定性和快速疫情应对的配送.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 疫苗接种对于预防传染病至关重要.
- 使者RNA (mRNA) 疫苗代表了一个先进的平台,与传统疫苗相比具有显著优势.
- 关键的好处包括没有感染风险和最小的基因组整合潜力.
研究的目的:
- 提供关于mRNA疫苗技术的全面概述.
- 讨论mRNA疫苗的历史发展和生产过程.
- 探索提高mRNA疫苗有效性和发放的策略.
主要方法:
- 审查关于mRNA疫苗开发的现有文献.
- 对mRNA生产技术和净化技术的分析.
- 检查改善mRNA稳定性和免疫反应的方法.
主要成果:
- mRNA疫苗只编码目标抗原,消除了病原体感染的风险.
- 表达仅限于细胞质,最小化宿主基因组的整合.
- 该平台允许快速对抗原进行修改,以便及时应对流行病.
- mRNA疫苗可以引起特定的细胞和幽默免疫,而无需抗载体反应.
结论:
- mRNA疫苗技术是预防传染病的强大而灵活的工具.
- 目前正在进行的研究重点是优化mRNA稳定性,输送和生产.
- 对于迅速应对新出现的传染性威胁,mRNA疫苗的适应性至关重要.
更多相关视频
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
相关概念视频
Regulated mRNA Transport
Microorganisms in Medicine and Therapeutics
Nuclear Export of mRNA
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
